Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Blood
    April 2024
  1. MONTORO J, Eikema DJ, Tuffnell J, Potter V, et al
    Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT.
    Blood. 2024 Apr 21:blood.2024024173. doi: 10.1182/blood.2024024173.
    >> Share

  2. DEZERN AE
    A way to "mimic" the pathophysiology of acquired SAA.
    Blood. 2024;143:1318-1320.
    >> Share

  3. GORDEUK VR
    Glad tidings and joy for children with SCA.
    Blood. 2024;143:1326-1327.
    >> Share

    March 2024
  4. MAJUMDER R, Mohammad MA
    Sickle cell anemia: hepatic macrophages to the rescue.
    Blood. 2024;143:1209-1210.
    >> Share

  5. SILVESTRI L
    Ironing erythroid cells takes FLG1 and ERFE to tango.
    Blood. 2024;143:1208-1209.
    >> Share

  6. SZER J
    C5 inhibition in PNH: still effective and safe.
    Blood. 2024;143:1064-1065.
    >> Share

  7. KELLY RJ, Holt M, Vidler J, Arnold LM, et al
    Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria.
    Blood. 2024;143:1157-1166.
    >> Share

  8. NOGUCHI CT
    Hemolysis impairs sickle cell erythropoiesis.
    Blood. 2024;143:947-949.
    >> Share

  9. BENZ EJ JR, Silberstein LE, Panepinto J
    "Treatment with curative intent": the emergence of genetic therapies for sickle cell anemia.
    Blood. 2024;143:967-970.
    >> Share

  10. LIU W, Wu Y, Wei H, Ma J, et al
    Lactate administration improves laboratory parameters in murine models of iron overload.
    Blood. 2024;143:1045-1049.
    >> Share

  11. HAN Y, Gao C, Liu Y, Zhang H, et al
    Hemolysis-driven IFNalpha production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.
    Blood. 2024;143:1018-1031.
    >> Share

  12. COATES TD
    Higher hemoglobin is better in thalassemia.
    Blood. 2024;143:842-844.
    >> Share

  13. PAREKH DS, Eaton WA, Thein SL
    Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.
    Blood. 2024;143:866-871.
    >> Share

  14. MUSALLAM KM, Barella S, Origa R, Ferrero GB, et al
    Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent beta-thalassemia.
    Blood. 2024;143:930-932.
    >> Share

  15. SAHA A, Palchaudhuri R, Lanieri L, Hyzy S, et al
    Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice.
    Blood. 2024 Mar 6:blood.2023023549. doi: 10.1182/blood.2023023549.
    >> Share

    February 2024
  16. FOGERTY AE, Kuter DJ
    How I treat thrombocytopenia in pregnancy.
    Blood. 2024;143:747-756.
    >> Share

  17. JAMES AH, Strouse JJ
    How I treat sickle cell disease in pregnancy.
    Blood. 2024;143:769-776.
    >> Share

  18. ORTEL TL
    Introduction to a How I Treat series on hematologic complications in pregnancy.
    Blood. 2024;143:739-740.
    >> Share

  19. D'SA S, Vos JMI, Barcellini W, Wardecki M, et al
    Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study.
    Blood. 2024;143:713-720.
    >> Share

  20. NINGTYAS DC, Leitner F, Sohail H, Thong YL, et al
    Platelets mediate the clearance of senescent red blood cells by forming prophagocytic platelet-cell complexes.
    Blood. 2024;143:535-547.
    >> Share

    January 2024
  21. BEN HAMZA A, Welters C, Stadler S, Bruggemann M, et al
    Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.
    Blood. 2024 Jan 26:blood.2023023142. doi: 10.1182/blood.2023023142.
    >> Share

  22. GUIZOUARN H
    Mechanosensation and lipid scrambling news.
    Blood. 2024;143:300-301.
    >> Share


  23. Keith J, Christakopoulos GE, Fernandez AG, et al. Loss of miR-144/451 alleviates beta-thalassemia by stimulating ULK1-mediated autophagy of free alpha-globin. Blood. 2023;142(10):918-932.
    Blood. 2024;143:377.
    >> Share

  24. LIANG P, Zhang Y, Wan YCS, Ma S, et al
    Deciphering and disrupting PIEZO1-TMEM16F interplay in hereditary xerocytosis.
    Blood. 2024;143:357-369.
    >> Share

  25. NAMAZZI R, Bond C, Conroy A, Datta D, et al
    Hydroxyurea reduces infections in children with sickle cell anemia in Uganda.
    Blood. 2024 Jan 3:blood.2023021575. doi: 10.1182/blood.2023021575.
    >> Share

    December 2023
  26. HELLSTROM-LINDBERG ES, Kroger N
    Clinical decision-making and treatment of myelodysplastic syndromes.
    Blood. 2023;142:2268-2281.
    >> Share

  27. SHI H, Gao L, Kirby N, Shao B, et al
    Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice.
    Blood. 2023 Dec 24:blood.2023021583. doi: 10.1182/blood.2023021583.
    >> Share

  28. SARDO U, Perrier P, Cormier K, Sotin M, et al
    The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling.
    Blood. 2023 Dec 24:blood.2023022724. doi: 10.1182/blood.2023022724.
    >> Share

  29. ATAGA KI
    The challenge of clinical end points in sickle cell disease.
    Blood. 2023;142:2047-2054.
    >> Share

    November 2023
  30. SPARKENBAUGH E, Little J
    Cold comfort in sickle cell disease.
    Blood. 2023;142:1854-1856.
    >> Share

  31. CAI J, Lee J
    Cold agglutinin syndrome with unexpected bone marrow CD5+ diffuse large B-cell lymphoma.
    Blood. 2023;142:1935.
    >> Share

  32. IVY ZK, Belcher JD, Khasabova IA, Chen C, et al
    Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.
    Blood. 2023;142:1918-1927.
    >> Share

  33. DENTON CC, Vodala S, Veluswamy S, Hofstra TC, et al
    Splenic iron decreases without change in volume or liver parameters during luspatercept therapy.
    Blood. 2023;142:1932-1934.
    >> Share

    October 2023
  34. VAN DE KAR NCAJ, Wetzels JFM
    Narrowing the knowledge gap in atypical HUS.
    Blood. 2023;142:1334-1335.
    >> Share


  35. C5 inhibition in aHUS.
    Blood. 2023;142:1406.
    >> Share

  36. BROCKLEBANK V, Walsh PR, Smith-Jackson K, Hallam TM, et al
    Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.
    Blood. 2023;142:1371-1386.
    >> Share


  37. d'Humieres T, Saba J, Savale L, et al. Determinants of ventricular arrhythmias in sickle cell anemia: toward better prevention of sudden cardiac death. Blood. 2023;142(5):409-420.
    Blood. 2023;142:1329.
    >> Share

  38. WU Z, Young NS
    Single-cell genomics in acquired bone marrow failure syndromes.
    Blood. 2023;142:1193-1207.
    >> Share

    September 2023
  39. SALIBA AN, Musallam KM, Taher AT
    How I treat non-transfusion-dependent beta-thalassemia.
    Blood. 2023;142:949-960.
    >> Share

  40. BABBS C
    The incredible ULK improves beta-thalassemia.
    Blood. 2023;142:862-863.
    >> Share

  41. KEITH J, Christakopoulos GE, Fernandez AG, Yao Y, et al
    Loss of miR-144/451 alleviates beta-thalassemia by stimulating ULK1-mediated autophagy of free alpha-globin.
    Blood. 2023;142:918-932.
    >> Share

    August 2023
  42. GODLEY LA
    Germ line risk variants: beyond cancer.
    Blood. 2023;142:616-617.
    >> Share

  43. MOLTENI E, Bono E, Galli A, Elena C, et al
    Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.
    Blood. 2023;142:643-657.
    >> Share

  44. JAVA A, Atkinson J, Hu Z, Pozzi N, et al
    Mutations in atypical hemolytic uremic syndrome provide evidence for the role of calcium in complement factor I.
    Blood. 2023;142:607-610.
    >> Share

  45. DESAI AA
    Ventricular arrhythmias in sickle cell anemia.
    Blood. 2023;142:399-400.
    >> Share

    July 2023
  46. XI C, Pang J, Zhi W, Chang CS, et al
    Nrf2 sensitizes ferroptosis through l-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease.
    Blood. 2023;142:382-396.
    >> Share

  47. TUBMAN VN, Mohandas N, Abrams CS
    New ASH initiatives to improve patient care in the long-overlooked sickle cell disease.
    Blood. 2023;142:230-234.
    >> Share

  48. SIMONEAU J, Shah YM
    Ironing out beta-thalassemia during pregnancy.
    Blood. 2023;142:128-129.
    >> Share

  49. YU Y, Woloshun RR, Lee JK, Ebea PO, et al
    Fetal factors disrupt placental and maternal iron homeostasis in murine beta-thalassemia.
    Blood. 2023;142:185-196.
    >> Share

    June 2023
  50. BRAMMER JE, Ballen K, Sokol L, Querfeld C, et al
    Effective Treatment with the Selective Cytokine Inhibitor BNZ-1 Reveals the Cytokine Dependency of T-LGL Leukemia.
    Blood. 2023 Jun 23:blood.2022017643. doi: 10.1182/blood.2022017643.
    >> Share

  51. DEEG HJ
    Reward from half a match.
    Blood. 2023;141:3009-3010.
    >> Share

  52. TOLOSANO E
    Heme and macrophages: a complicated liaison.
    Blood. 2023;141:3015-3017.
    >> Share

  53. FERRER-VICENS I, Ferguson DCJ, Wilson MC, Heesom KJ, et al
    A novel human cellular model of CDA IV enables comprehensive analysis revealing the molecular basis of the disease phenotype.
    Blood. 2023;141:3039-3054.
    >> Share

  54. SHARMA R, Antypiuk A, Vance SZ, Manwani D, et al
    Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease.
    Blood. 2023;141:3091-3108.
    >> Share

  55. LAM WK, Yip SF
    Cytopenic AML with marrow fibrosis and multihit TP53 abnormalities.
    Blood. 2023;141:3006.
    >> Share

  56. DEAN A
    Help on the way to unsilence HbF.
    Blood. 2023;141:2670-2672.
    >> Share

  57. DEAN A
    Help on the way to unsilence HbF.
    Blood. 2023;141:2670-2672.
    >> Share

    May 2023
  58. BENJAMIN RJ
    Cytosolic antigens prime RBC alloantibodies.
    Blood. 2023;141:2550-2551.
    >> Share

  59. D'HUMIERES T, Saba J, Savale L, Dupuy M, et al
    Determinants of Ventricular Arrhythmias in Sickle Cell Anemia: Towards a Better Prevention of Sudden Cardiac Death.
    Blood. 2023 May 22:blood.2022019571. doi: 10.1182/blood.2022019571.
    >> Share

  60. HESLOP HE
    Introduction to a How I Treat series on emergent CAR T-cell toxicities.
    Blood. 2023;141:2405-2407.
    >> Share

    April 2023
  61. LI C, Georgakopoulou A, Newby GA, Chen PJ, et al
    In vivo HSC prime editing rescues sickle cell disease in a mouse model.
    Blood. 2023;141:2085-2099.
    >> Share

  62. GUTIERREZ-RODRIGUES F, Munger E, Ma X, Groarke EM, et al
    Differential diagnosis of bone marrow failure syndromes guided by machine learning.
    Blood. 2023;141:2100-2113.
    >> Share

  63. DEZERN A, Zahurak ML, Symons HJ, Cooke KR, et al
    Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
    Blood. 2023 Apr 21:blood.2023020435. doi: 10.1182/blood.2023020435.
    >> Share

  64. LANGER AL
    Love's labor's lost? Fetal vs maternal AIHA outcomes.
    Blood. 2023;141:1906-1907.
    >> Share

  65. GURNARI C, Prata PH, Catto LFB, Durmaz A, et al
    IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria.
    Blood. 2023 Apr 13:blood.2023020108. doi: 10.1182/blood.2023020108.
    >> Share

  66. SHET AS
    FXII and sickle cell: the clot thickens.
    Blood. 2023;141:1787-1789.
    >> Share

  67. RISITANO AM
    PNH and complement gene variants.
    Blood. 2023;141:1780-1782.
    >> Share

  68. SPARKENBAUGH EM, Henderson MW, Miller-Awe M, Abrams C, et al
    Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease.
    Blood. 2023;141:1871-1883.
    >> Share

  69. PRATA PH, Galimard JE, Sicre de Fontbrune F, Duval A, et al
    Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria.
    Blood. 2023;141:1812-1816.
    >> Share


  70. Walter O, Cougoul P, Maquet J, et al. Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease. Blood. 2022;139(26):3771-3777.
    Blood. 2023;141:1778.
    >> Share

    March 2023
  71. SUKUMAR S, Sasa G
    Blocking COX unlocks response in GHDD.
    Blood. 2023;141:1497-1498.
    >> Share

  72. BROWN TJ, Barrett N, Meng H, Ricciotti E, et al
    Nonsteroidal anti-inflammatory drugs as a targeted therapy for bone marrow failure in Ghosal hematodiaphyseal dysplasia.
    Blood. 2023;141:1553-1559.
    >> Share

  73. ODAME I
    HU for SCA in Africa: associated malaria benefit.
    Blood. 2023;141:1370-1371.
    >> Share

  74. HAKKARAINEN M, Kaaja I, Douglas SPM, Vulliamy TJ, et al
    The Clinical Picture of the ERCC6L2 Disease - from Bone Marrow Failure to Acute Leukemia.
    Blood. 2023 Mar 23:blood.2022019425. doi: 10.1182/blood.2022019425.
    >> Share

  75. HAMMOUDI N, Lionnet F
    Heart failure in SCA: still challenging.
    Blood. 2023;141:1248-1249.
    >> Share

  76. AYOUB PG, Kohn DB
    beta-Thalassemia: all about that base, no cutting.
    Blood. 2023;141:1098-1099.
    >> Share

  77. MATSON DR, Matkovic E
    Peripheral erythrophagocytosis in paroxysmal cold hemoglobinuria.
    Blood. 2023;141:1233.
    >> Share

  78. HARDOUIN G, Antoniou P, Martinucci P, Felix T, et al
    Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) beta-thalassemia mutation.
    Blood. 2023;141:1169-1179.
    >> Share


  79. Ludwig LS, Lareau CA, Bao EL, et al. Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1. Blood. 2022;139(16):2534-2546.
    Blood. 2023;141:1094.
    >> Share

  80. FAKHOURI F, Schwotzer N, Fremeaux-Bacchi V
    How I diagnose and treat atypical hemolytic uremic syndrome.
    Blood. 2023;141:984-995.
    >> Share

    February 2023
  81. OYEDEJI CI, Artz AS, Cohen HJ
    How I Treat Anemia in Older Adults.
    Blood. 2023 Feb 24:blood.2022017626. doi: 10.1182/blood.2022017626.
    >> Share

  82. QUINN CT
    Hydroxyurea: how much is enough?
    Blood. 2023;141:813-814.
    >> Share


  83. Camaschella C. Iron deficiency. Blood. 2019;133(1):30-39.
    Blood. 2023;141:682.
    >> Share

    January 2023
  84. FATTIZZO B, Bortolotti M, Fantini NN, Glenthoj A, et al
    AUTOIMMUNE HEMOLYTIC ANEMIA DURING PREGNANCY AND PUERPERIUM: AN INTERNATIONAL MULTI-CENTER EXPERIENCE.
    Blood. 2023 Jan 27:blood.2022018890. doi: 10.1182/blood.2022018890.
    >> Share

  85. WOOD JC
    Anemia and brain hypoxia.
    Blood. 2023;141:327-328.
    >> Share


  86. Barcellini W, Fattizzo B. How I treat warm autoimmune hemolytic anemia. Blood. 2021;137(10):1283-1294.
    Blood. 2023;141:438-439.
    >> Share

  87. PARROW NL, Fleming RE
    Transferrin receptor 1: keeper of HFE.
    Blood. 2023;141:332-333.
    >> Share

  88. TARFI S, Badaoui B
    Four genetic red cell disorders in one.
    Blood. 2023;141:436.
    >> Share

  89. XIAO X, Moschetta GA, Xu Y, Fisher AL, et al
    Regulation of iron homeostasis by hepatocyte TfR1 requires HFE and contributes to hepcidin suppression in beta-thalassemia.
    Blood. 2023;141:422-432.
    >> Share

  90. BROUSSE V
    Ups and downs in the treatment of sickle cell disease.
    Blood. 2023;141:125-127.
    >> Share

  91. DAS NK, Shah YM
    (De)ironing out sickle cell disease.
    Blood. 2023;141:129-130.
    >> Share

  92. KARAMATIC CREW V, Tilley LA, Satchwell TJ, AlSubhi SA, et al
    Missense mutations in PIEZO1, which encodes the Piezo1 mechanosensor protein, define Er red blood cell antigens.
    Blood. 2023;141:135-146.
    >> Share

  93. CURTIS SA, Novelli EM
    Is CBD ready for prime time in sickle cell disease?
    Blood. 2023;141:132-133.
    >> Share

  94. LI H, Kazmi JS, Lee S, Zhang D, et al
    Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease.
    Blood. 2023;141:194-199.
    >> Share

  95. CHERUKURY HM, Argueta DA, Garcia N, Fouda R, et al
    Cannabidiol attenuates hyperalgesia in a mouse model of sickle cell disease.
    Blood. 2023;141:203-208.
    >> Share

  96. DAMPIER CD, Telen MJ, Wun T, Brown RC, et al
    A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
    Blood. 2023;141:168-179.
    >> Share

  97. GROARKE EM, Feng X, Aggarwal N, Manley AL, et al
    Efficacy of JAK1/2 inhibition in murine immune bone marrow failure.
    Blood. 2023;141:72-89.
    >> Share

  98. GRIFFIN M, Muus P, Munir T, Nagumantry S, et al
    Experience of compassionate-use pegcetacoplan for paroxysmal nocturnal hemoglobinuria.
    Blood. 2023;141:116-120.
    >> Share

    December 2022

  99. Galli A, Todisco G, Catamo E, et al. Relationship between clone metrics and clinical outcome in clonal cytopenia. Blood. 2021;138(11):965-976.
    Blood. 2022;140:2858.
    >> Share

  100. SULLIVAN JC, Comenzo R
    Peripheral agglutination and hemolytic anemia following minor ABO-mismatch hematopoietic progenitor cell transplantation.
    Blood. 2022;140:2412.
    >> Share

    November 2022
  101. MORIN C, Sharma A, Selukar S, Beasley G, et al
    Diffuse Myocardial Fibrosis Occurs in Young Patients with Sickle Cell Anemia Despite Early Disease Modifying Therapy.
    Blood. 2022 Nov 28:blood.2022018209. doi: 10.1182/blood.2022018209.
    >> Share

  102. FLAUMENHAFT R
    Platelets: out of shape and misbehaving.
    Blood. 2022;140:2188-2190.
    >> Share

  103. KUTLAR A
    A-two to the rescue.
    Blood. 2022;140:2187-2188.
    >> Share

  104. ZHU J, Li H, Aerbajinai W, Kumkhaek C, et al
    Kruppel-like factor 1-GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo.
    Blood. 2022;140:2276-2289.
    >> Share

  105. OLUPOT-OLUPOT P, Tomlinson G, Williams TN, Tshilolo LMM, et al
    Hydroxyurea is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa.
    Blood. 2022 Nov 14. pii: 487110. doi: 10.1182/blood.2022017051.
    >> Share

  106. LITTLE JA
    RBC, heal thyself: PK activators in SCD.
    Blood. 2022;140:2005-2006.
    >> Share

  107. XU JZ, Conrey A, Frey I, Gwaabe E, et al
    A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease.
    Blood. 2022;140:2053-2062.
    >> Share

  108. GIBB DR, Hudson KE
    Sickle cell inflammation: is HbS the answer?
    Blood. 2022;140:1921-1923.
    >> Share

  109. ALLALI S, Rignault-Bricard R, de Montalembert M, Taylor M, et al
    HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease.
    Blood. 2022;140:1972-1982.
    >> Share

  110. ABDULLAHI S, Sunusi SM, Abba MS, Sani S, et al
    Hydroxyurea for Secondary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria:a Randomized Controlled Trial.
    Blood. 2022 Nov 2. pii: 486968. doi: 10.1182/blood.2022016620.
    >> Share

    October 2022
  111. CARSON JL, Brittenham GM
    How I Treat Anemia with Red Blood Cell Transfusion and Iron.
    Blood. 2022 Oct 31. pii: 486955. doi: 10.1182/blood.2022018521.
    >> Share

  112. KHASABOVA II, Juliette J, Rogness VM, Khasabov SG, et al
    A model of painful vaso-occlusive crisis in mice with sickle cell disease.
    Blood. 2022;140:1826-1830.
    >> Share

  113. CARSETTI R, Agrati C, Pinto VM, Gianesin B, et al
    Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in beta-thalassemia: role of an additional dose.
    Blood. 2022;140:1735-1738.
    >> Share

    September 2022
  114. PECKER LH, Ellsworth P
    Raise the roof, build the floor.
    Blood. 2022;140:1453-1455.
    >> Share

  115. HEENEY MM, Abboud MR, Githanga J, Inusa BPD, et al
    Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study.
    Blood. 2022;140:1470-1481.
    >> Share

  116. THEIN SL, Sachdev V
    Diffuse myocardial fibrosis as an SCD biomarker.
    Blood. 2022;140:1191-1192.
    >> Share


  117. Tumburu L, Ghosh-Choudhary S, Seifuddin FT, et al. Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell disease. Blood. 2021;137(22):3116-3126.
    Blood. 2022;140:1327.
    >> Share

  118. TORRES LS, Hidalgo A
    NETs in sickle cell disease, quo vadis?
    Blood. 2022;140:938-939.
    >> Share

  119. CHONAT S, Stowell SR
    A virtuosic CADENZA played by sutimlimab.
    Blood. 2022;140:933-935.
    >> Share

  120. VATS R, Kaminski TW, Brzoska T, Leech JA, et al
    Liver-to-lung microembolic NETs promote gasdermin D-dependent inflammatory lung injury in sickle cell disease.
    Blood. 2022;140:1020-1037.
    >> Share

  121. ROTH A, Berentsen S, Barcellini W, D'Sa S, et al
    Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.
    Blood. 2022;140:980-991.
    >> Share

    August 2022
  122. HULBERT ML, Fields ME, Guilliams KP, Bijlani P, et al
    Normalization of cerebral hemodynamics following hematopoietic stem cell transplant in children with sickle cell disease.
    Blood. 2022 Aug 30. pii: 486449. doi: 10.1182/blood.2022016618.
    >> Share

  123. DEZERN AE
    Playing with fire: unrecognized AA genetic predisposition.
    Blood. 2022;140:805-807.
    >> Share

  124. MARQUES O, Weiss G, Muckenthaler MU
    The role of iron in chronic inflammatory diseases - from mechanisms to treatment options in Anemia of Inflammation.
    Blood. 2022 Aug 22. pii: 486362. doi: 10.1182/blood.2021013472.
    >> Share

  125. PARROW NL, Fleming RE
    Isn't it ironic: better RBCs by blocking iron.
    Blood. 2022;140:669-670.
    >> Share


  126. Vats R, Kaminski TW, Ju E-M, et al. P-selectin deficiency promotes liver senescence in sickle cell disease mice. Blood. 2021;137(19):2676-2680.
    Blood. 2022;140:794.
    >> Share

  127. FATTIZZO B, Cecchi N, Bortolotti M, Giordano G, et al
    Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience.
    Blood. 2022;140:789-792.
    >> Share

  128. NYFFENEGGER N, Zennadi R, Kalleda N, Flace A, et al
    The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.
    Blood. 2022;140:769-781.
    >> Share

  129. DOKAL I, Tummala H, Vulliamy T
    Inherited bone marrow failure in the pediatric patient.
    Blood. 2022;140:556-570.
    >> Share

    July 2022
  130. PINCEZ T, Aladjidi N, Heritier S, Garnier N, et al
    Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias.
    Blood. 2022;140:253-261.
    >> Share

  131. NISS O, Detterich JA, Wood JC, Coates TD, et al
    Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemia.
    Blood. 2022 Jul 20. pii: 485971. doi: 10.1182/blood.2021015303.
    >> Share

  132. MCREYNOLDS LJ, Rafati M, Wang Y, Ballew BJ, et al
    Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.
    Blood. 2022 Jul 1. pii: 485762. doi: 10.1182/blood.2022016508.
    >> Share

    June 2022
  133. LANZKRON S, Pecker L
    Pain without gain: steroids and sickle crisis.
    Blood. 2022;139:3678-3679.
    >> Share

  134. THAKRAL B, Bueso-Ramos CE
    Unexpected presentation of cold agglutinin syndrome with B-acute lymphoblastic leukemia.
    Blood. 2022;139:3778.
    >> Share

  135. WALTER O, Cougoul P, Maquet J, Bartolucci P, et al
    Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease.
    Blood. 2022;139:3771-3777.
    >> Share

  136. KROLL MH, Rojas-Hernandez C, Yee C
    Hematologic complications of immune checkpoint inhibitors.
    Blood. 2022;139:3594-3604.
    >> Share

  137. GAVRIILAKI E, de Latour RP, Risitano AM
    Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond.
    Blood. 2022;139:3571-3582.
    >> Share

  138. GERBER GF, Brodsky RA
    Pegcetacoplan for paroxysmal nocturnal hemoglobinuria.
    Blood. 2022;139:3361-3365.
    >> Share

  139. DOTY RT, Fan X, Young DJ, Liang J, et al
    Studies of a mosaic patient with DBA and chimeric mice reveal erythroid cell-extrinsic contributions to erythropoiesis.
    Blood. 2022;139:3439-3449.
    >> Share

    May 2022
  140. ISKANDER D, Warren AJ
    Turning up the HEAT(R3) in Diamond-Blackfan anemia.
    Blood. 2022;139:3101-3102.
    >> Share

  141. BODINE DM
    Anemia of inflammation is all the RAGE.
    Blood. 2022;139:3106-3107.
    >> Share

  142. XU JZ, Thein SL
    Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches.
    Blood. 2022;139:3030-3039.
    >> Share

    April 2022
  143. NOVELLI EM
    Extinguishing the fire in sickle cell anemia.
    Blood. 2022;139:2578-2580.
    >> Share

  144. DAS NK, Jain C, Sankar A, Schwartz AJ, et al
    Modulation of the HIF2alpha-NCOA4 axis in enterocytes attenuates iron loading in a mouse model of hemochromatosis.
    Blood. 2022;139:2547-2552.
    >> Share

  145. WHITE NJ
    What causes malaria anemia?
    Blood. 2022;139:2268-2269.
    >> Share

  146. MAHAMAR A, Gonzales Hurtado PA, Morrison R, Boone R, et al
    Plasma biomarkers of hemoglobin loss in Plasmodium falciparum-infected children identified by quantitative proteomics.
    Blood. 2022;139:2361-2376.
    >> Share

  147. NWOGBO OV, Loghavi S
    Essential thrombocythemia complicating hemoglobin SC disease and presenting with priapism.
    Blood. 2022;139:2258.
    >> Share

  148. WANG M, Dingler FA, Patel KJ
    Genotoxic aldehydes in the hematopoietic system.
    Blood. 2022;139:2119-2129.
    >> Share

  149. TOPFER SK, Feng R, Huang P, Ly LC, et al
    Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression.
    Blood. 2022;139:2107-2118.
    >> Share

    March 2022
  150. CAZZOLA M
    RNA missplicing and ring sideroblasts in MDS.
    Blood. 2022;139:1933-1935.
    >> Share

  151. WOOD JC
    Pulmonary hypertension in thalassemia: a call to action.
    Blood. 2022;139:1937-1938.
    >> Share

  152. PINTO VM, Musallam KM, Derchi G, Graziadei G, et al
    Mortality in beta-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization.
    Blood. 2022;139:2080-2083.
    >> Share

  153. SCHMIDT CQ, Schrezenmeier H, Kavanagh D
    Complement and the prothrombotic state.
    Blood. 2022;139:1954-1972.
    >> Share

  154. DOSUNMU-OGUNBI A, Yuan S, Reynolds M, Giordano L, et al
    SOD2 V16A amplifies vascular dysfunction in sickle cell patients by curtailing mitochondria complex IV activity.
    Blood. 2022;139:1760-1765.
    >> Share

  155. MESSONNIER LA
    Mitochondrial function in sickle cell disease.
    Blood. 2022;139:1616-1617.
    >> Share

  156. WONTAKAL SN, Britto M, Zhang H, Han Y, et al
    RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the disease.
    Blood. 2022;139:1413-1418.
    >> Share

    February 2022
  157. REES DC, Kilinc Y, Unal S, Dampier CD, et al
    A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia.
    Blood. 2022 Feb 28. pii: 484189. doi: 10.1182/blood.2021013674.
    >> Share

  158. O'DONOHUE MF, Da Costa LM, Lezzerini M, Unal S, et al
    HEATR3 variants impair nuclear import of uL18 (RPL5) and drive Diamond-Blackfan anemia.
    Blood. 2022 Feb 25. pii: 484180. doi: 10.1182/blood.2021011846.
    >> Share

  159. GALLAGHER PG
    Anemia in the pediatric patient.
    Blood. 2022 Feb 25. pii: 484178. doi: 10.1182/blood.2020006479.
    >> Share

  160. MENON AV, Liu J, Tsai HP, Zeng L, et al
    Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease.
    Blood. 2022;139:936-941.
    >> Share

    January 2022
  161. NEUMANN NM, Wen KW
    Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts, thrombocytosis, and mutated JAK2/SF3B1 without anemia.
    Blood. 2022;139:466.
    >> Share

  162. RAO VK
    Evans syndrome: pathology and genomic hubris.
    Blood. 2022;139:312-313.
    >> Share

  163. KUMAR D, Prince C, Bennett CM, Briones M, et al
    T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome.
    Blood. 2022;139:369-383.
    >> Share

  164. DULMOVITS BM, Tang Y, Papoin J, He M, et al
    HMGB1-Mediated Restriction of EPO Signaling Contributes to Anemia of Inflammation.
    Blood. 2022 Jan 18. pii: 483547. doi: 10.1182/blood.2021012048.
    >> Share

  165. LUDWIG L, Lareau CA, Bao EL, Liu N, et al
    A Congenital Anemia Reveals Distinct Targeting Mechanisms for Master Transcription Factor GATA1.
    Blood. 2022 Jan 14. pii: 483530. doi: 10.1182/blood.2021013753.
    >> Share

  166. DHUNPUTH C, Ducassou S, Fernandes H, Picard C, et al
    Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects.
    Blood. 2022;139:300-304.
    >> Share

    December 2021
  167. PAGLIUCA S, Gurnari C, Awada H, Kishtagari A, et al
    The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders.
    Blood. 2021;138:2781-2798.
    >> Share

  168. TANG A, Strat AN, Rahman M, Zhang H, et al
    Murine bone marrow mesenchymal stromal cells have reduced hematopoietic maintenance ability in sickle cell disease.
    Blood. 2021;138:2570-2582.
    >> Share

  169. PECKER L, Hussain S, Mahesh J, Varadhan R, et al
    Diminished ovarian reserve in young women with sickle cell anemia.
    Blood. 2021 Dec 5. pii: 482897. doi: 10.1182/blood.2021012756.
    >> Share

  170. MARTIN MERINERO H, Zhang Y, Arjona E, Del Angel G, et al
    Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification.
    Blood. 2021;138:2185-2201.
    >> Share

    November 2021
  171. DUCHEMANN B, Lazarian G
    Post-SARS-CoV-2 vaccination acute hemolysis in an older man: don't forget to look at the blood smear.
    Blood. 2021;138:2153.
    >> Share

  172. PINCEZ T, Lee SSK, Ilboudo Y, Preuss M, et al
    Clonal hematopoiesis in sickle cell disease.
    Blood. 2021;138:2148-2152.
    >> Share

  173. LUZZATTO L
    Control of hemolysis in patients with PNH.
    Blood. 2021;138:1908-1910.
    >> Share

  174. KULASEKARARAJ AG, Risitano AM, Maciejewski JP, Notaro R, et al
    Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab.
    Blood. 2021;138:1928-1938.
    >> Share

  175. EL SISSY C, Saldman A, Zanetta G, Martins PV, et al
    COVID-19 as a potential trigger of complement-mediated atypical HUS.
    Blood. 2021;138:1777-1782.
    >> Share

  176. FENG Y, Feng W
    Numerous ring sideroblasts in chronic neutrophilic leukemia.
    Blood. 2021;138:1783.
    >> Share

  177. ZAIMOKU Y, Patel BA, Adams SD, Shalhoub RN, et al
    HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
    Blood. 2021 Nov 1. pii: 477734. doi: 10.1182/blood.2021012895.
    >> Share

    September 2021
  178. HENRY ER, Metaferia B, Li Q, Harper J, et al
    Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin.
    Blood. 2021;138:1172-1181.
    >> Share

  179. LIU Y, Pal M, Bao W, Shi PA, et al
    Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease.
    Blood. 2021;138:1162-1171.
    >> Share

  180. IRELAND RM, Rees DC
    Two brothers with a novel KLF1 mutation.
    Blood. 2021;138:1087.
    >> Share

  181. ABRAHAM AA, Tisdale JF
    Gene therapy for sickle cell disease: moving from the bench to the bedside.
    Blood. 2021;138:932-941.
    >> Share

  182. BOLLARD CM
    Introduction to a review series on gene therapy and gene editing for sickle cell disease and hemophilia.
    Blood. 2021;138:913.
    >> Share

  183. PATEL BA, Groarke EM, Lotter J, Shalhoub RN, et al
    Long-term outcomes in severe aplastic anemia patients treated with immunosuppression and eltrombopag: a phase 2 study.
    Blood. 2021 Sep 15. pii: 476916. doi: 10.1182/blood.2021012130.
    >> Share

    August 2021
  184. COCHRAN T, Li W
    Frequent internuclear bridging in a Fanconi anemia patient with FANCG mutation.
    Blood. 2021;138:738.
    >> Share

  185. XU Z, Mueller R
    Myelodysplastic pure red cell aplasia.
    Blood. 2021;138:500.
    >> Share

    July 2021
  186. JALINK M, Berentsen S, Castillo J, Treon SPP, et al
    Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome.
    Blood. 2021 Jul 22. pii: 476451. doi: 10.1182/blood.2021012039.
    >> Share

  187. RICE L, Schwartz MR
    Sickle cell hepatopathy with spur cell anemia.
    Blood. 2021;138:283.
    >> Share

  188. GERBER GF, Yuan X, Yu J, Cher BAY, et al
    COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria.
    Blood. 2021;137:3670-3673.
    >> Share

    June 2021
  189. MORENO C
    Autoimmune cytopenia and CLL ride together.
    Blood. 2021;137:3464-3465.
    >> Share

  190. MARTIN MERINERO H, Subias M, Pereda A, Gomez-Rubio E, et al
    Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases.
    Blood. 2021;137:3484-3494.
    >> Share

  191. REJESKI K, Perez Perez A, Sesques P, Hoster E, et al
    CAR-HEMATOTOX: A model for CAR T-cell related hematological toxicity in relapsed/refractory large B-cell lymphoma.
    Blood. 2021 Jun 24. pii: 476241. doi: 10.1182/blood.2020010543.
    >> Share

  192. PSATHA N, Georgakopoulou A, Li C, Nandakumar V, et al
    Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo.
    Blood. 2021 Jun 4. pii: 476068. doi: 10.1182/blood.2020010020.
    >> Share

  193. RARICK KR, Pritchard KA
    The sickle erythrocyte yields another DAMP.
    Blood. 2021;137:3010-3011.
    >> Share

  194. JONES RJ, DeBaun MR
    Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both or neither.
    Blood. 2021 Jun 3. pii: 476065. doi: 10.1182/blood.2021011488.
    >> Share

  195. TUMBURU L, Ghosh-Choudhary S, Seifuddin FT, Barbu EA, et al
    Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell disease.
    Blood. 2021;137:3116-3126.
    >> Share

    May 2021
  196. RAB MAE, Bos J, van Oirschot BA, van Straaten S, et al
    Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy.
    Blood. 2021;137:2997-3001.
    >> Share

  197. MANWANI D
    P-selectin and sickle cell disease: a balancing act.
    Blood. 2021;137:2573-2574.
    >> Share

  198. VATS R, Kaminski TW, Ju EM, Brozska T, et al
    P-selectin deficiency promotes liver senescence in sickle cell disease mice.
    Blood. 2021;137:2676-2680.
    >> Share

  199. BRODSKY RA
    Eculizumab and aHUS: to stop or not.
    Blood. 2021;137:2419-2420.
    >> Share

  200. FAKHOURI F, Fila M, Hummel A, Ribes D, et al
    Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study.
    Blood. 2021;137:2438-2449.
    >> Share

    April 2021
  201. CERCAMONDI CI, Stoffel N, Moretti D, Zoller T, et al
    Iron homeostasis during anemia of inflammation: a prospective study in patients with tuberculosis.
    Blood. 2021 Apr 19. pii: 475787. doi: 10.1182/blood.2020010562.
    >> Share

  202. SHAH N
    ELIPSIS: developing tools to better understand VOC in SCD.
    Blood. 2021;137:1987-1988.
    >> Share

  203. GURNARI C, Maciejewski JP
    How I manage acquired pure red cell aplasia in adults.
    Blood. 2021;137:2001-2009.
    >> Share

  204. PITTMAN DD, Hines PC, Beidler D, Rybin D, et al
    Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers.
    Blood. 2021;137:2010-2020.
    >> Share

  205. TURNIS ME, Kaminska E, Smith KH, Kartchner BJ, et al
    Requirement for antiapoptotic MCL-1 during early erythropoiesis.
    Blood. 2021;137:1945-1958.
    >> Share

    March 2021
  206. GONG Y, Zhang X, Zhang Q, Zhang Y, et al
    A natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the gamma-globin gene in beta-thalassemia.
    Blood. 2021;137:1652-1657.
    >> Share

  207. ZHU C, Lian Y, Wang C, Wu P, et al
    Single-cell transcriptomics dissects hematopoietic cell destruction and T cell engagement in aplastic anemia.
    Blood. 2021 Mar 24. pii: 475591. doi: 10.1182/blood.2020008966.
    >> Share

  208. HOSOKAWA K, Mizumaki H, Yoroidaka T, Maruyama H, et al
    HLA class I allele-lacking leukocytes predict rare clonal evolution to MDS/AML in patients with acquired aplastic anemia.
    Blood. 2021 Mar 22. pii: 475586. doi: 10.1182/blood.2020010586.
    >> Share

  209. BRUGNARA C
    Less (Fe) is more (Hb) in SCA.
    Blood. 2021;137:1446-1447.
    >> Share

  210. ANSARI J, Senchenkova EY, Vital SA, Al-Yafeai Z, et al
    Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease.
    Blood. 2021;137:1538-1549.
    >> Share

  211. ELDAR D, Ganzel C
    Erythrophagocytosis in a young adult with mycoplasma pneumonia-induced paroxysmal cold hemoglobinuria.
    Blood. 2021;137:1432.
    >> Share

  212. BERENTSEN S
    How I treat cold agglutinin disease.
    Blood. 2021;137:1295-1303.
    >> Share

  213. BRODSKY RA
    How I treat paroxysmal nocturnal hemoglobinuria.
    Blood. 2021;137:1304-1309.
    >> Share

  214. ZHABYEYEV P, Oudit GY
    Sickle cell disease, interleukin-18, and arrhythmias.
    Blood. 2021;137:1138-1139.
    >> Share

  215. GUPTA A, Fei YD, Kim TY, Xie A, et al
    IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias.
    Blood. 2021;137:1208-1218.
    >> Share

    February 2021
  216. WACHTER F, Archer NM
    Autoimmune hemolytic anemia complicated by parvovirus infection.
    Blood. 2021;137:1130.
    >> Share

  217. GU Y, Yang R, Yang Y, Zhao Y, et al
    IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis.
    Blood. 2021;137:945-958.
    >> Share

  218. AL-SAMKARI H
    Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
    Blood. 2021;137:888-895.
    >> Share

  219. WARE RE, Dertinger SD
    There's safety in numbers.
    Blood. 2021;137:729-731.
    >> Share

  220. REES DC
    Hydroxyurea: coming to conclusions on safety.
    Blood. 2021;137:728-729.
    >> Share

  221. GILLE AS, Pondarre C, Dalle JH, Bernaudin F, et al
    Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease.
    Blood. 2021;137:856-859.
    >> Share

  222. JOSEPH L, Jean C, Manceau S, Chalas C, et al
    Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease.
    Blood. 2021;137:826-829.
    >> Share

  223. SHENG Y, Ma R, Yu C, Wu Q, et al
    Role of c-Myc haploinsufficiency in the maintenance of HSCs in mice.
    Blood. 2021;137:610-623.
    >> Share

    January 2021
  224. BADAT M, Davies JOJ, Fisher CA, Downes DJ, et al
    A remarkable case of HbH disease illustrates the relative contributions of the alpha-globin enhancers to gene expression.
    Blood. 2021;137:572-575.
    >> Share

  225. DEANS AJ
    Fanconi anemia, put to sleep.
    Blood. 2021;137:286-288.
    >> Share

  226. THOMAS M, Scully M
    How I Treat Microangiopathic Hemolytic Anemia in Patients with Cancer.
    Blood. 2021 Jan 21. pii: 475029. doi: 10.1182/blood.2019003810.
    >> Share

  227. CAZZOLA M
    Introduction to a How I Treat Series on Acquired Hemolytic Anemia.
    Blood. 2021 Jan 21. pii: 475027. doi: 10.1182/blood.2020009747.
    >> Share

  228. BARCELLINI W, Fattizzo B
    How I treat warm autoimmune hemolytic anemia.
    Blood. 2021 Jan 21. pii: 475030. doi: 10.1182/blood.2019003808.
    >> Share

  229. PIRENNE F
    Heme control to major B (cell): are you listening?
    Blood. 2021;137:153-154.
    >> Share

  230. PAL M, Bao W, Wang R, Liu Y, et al
    Hemolysis inhibits humoral B-cell responses and modulates alloimmunization risk in patients with sickle cell disease.
    Blood. 2021;137:269-280.
    >> Share

  231. MU A, Hira A, Niwa A, Osawa M, et al
    Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency.
    Blood. 2021 Jan 12. pii: 474923. doi: 10.1182/blood.2020009111.
    >> Share

  232. SALIB C, Hussein S
    A case of hairy cell leukemia with markedly hypocellular marrow mimicking aplastic anemia.
    Blood. 2021;137:142.
    >> Share

    December 2020
  233. SICA M, Pellecchia A, De Angioletti M, Caocci G, et al
    Complement-mediated oxidative damage of red cells impairs response to eculizumab in a G6PD-deficient patient with PNH.
    Blood. 2020;136:3082-3085.
    >> Share

  234. MARIANI R, Liu H
    Severe transient pancytopenia with dyserythropoiesis and dysmegakaryopoiesis in COVID-19-associated MIS-C.
    Blood. 2020;136:2964.
    >> Share

  235. ARORA S, Ganapathi KA
    Prominent pseudo-Gaucher cells in a patient with beta-thalassemia intermedia and plasma cell myeloma.
    Blood. 2020;136:2839.
    >> Share

  236. PARROW NL, Violet PC, Ajit George N, Ali F, et al
    Dietary Iron Restriction Improves Markers of Disease Severity in Murine Sickle Cell Anemia.
    Blood. 2020 Dec 8. pii: 474426. doi: 10.1182/blood.2020006919.
    >> Share

    November 2020
  237. ABKOWITZ JL
    A simple Rx for congenital erythropoietic porphyria.
    Blood. 2020;136:2371-2372.
    >> Share

    October 2020
  238. DEWARRAT N, Blum S
    Heavy metal.
    Blood. 2020;136:1993.
    >> Share

    September 2020
  239. ARJONA E, Huerta A, Goicoechea de Jorge E, Rodriguez de Cordoba S, et al
    Familial risk of developing atypical hemolytic-uremic syndrome.
    Blood. 2020;136:1558-1561.
    >> Share

  240. KIM-SHAPIRO DB, Gladwin MT
    Arginine for mitochondrial oxidative enzymopathy.
    Blood. 2020;136:1376-1378.
    >> Share

  241. MORRIS CR, Brown LAS, Reynolds M, Dampier CD, et al
    Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.
    Blood. 2020;136:1402-1406.
    >> Share

  242. LUZZATTO L, Ally M, Notaro R
    Glucose-6-phosphate dehydrogenase deficiency.
    Blood. 2020;136:1225-1240.
    >> Share

  243. SCHELL B, Fenneteau O
    Brandalise syndrome: a rare inclusion cell disease.
    Blood. 2020;136:1373.
    >> Share

  244. RISINGER M, Kalfa TA
    Red cell membrane disorders: structure meets function.
    Blood. 2020;136:1250-1261.
    >> Share

  245. CAZZOLA M
    Introduction to a review series on inherited anemias.
    Blood. 2020;136:1215-1216.
    >> Share

  246. IOLASCON A, Andolfo I, Russo R
    Congenital dyserythropoietic anemias.
    Blood. 2020;136:1274-1283.
    >> Share

  247. GRACE RF, Barcellini W
    Management of pyruvate kinase deficiency in children and adults.
    Blood. 2020;136:1241-1249.
    >> Share

  248. BROUSSE V, Connes P
    Vasomotor hyperresponsiveness in SCD.
    Blood. 2020;136:1120-1121.
    >> Share

  249. VELUSWAMY S, Shah P, Khaleel M, Thuptimdang W, et al
    Progressive vasoconstriction with sequential thermal stimulation indicates vascular dysautonomia in sickle cell disease.
    Blood. 2020;136:1191-1200.
    >> Share

    August 2020
  250. VOIT RA, Grace RF
    Pyruvate kinase deficiency in a newborn with extramedullary hematopoiesis in the skin.
    Blood. 2020;136:770.
    >> Share

    July 2020
  251. CARLESSO N
    Targeting the bone marrow niche in hemoglobinopathies.
    Blood. 2020;136:529-531.
    >> Share

  252. BRAZAUSKAS R, Scigliuolo GM, Wang HL, Cappelli B, et al
    Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.
    Blood. 2020;136:623-626.
    >> Share

  253. ROTH A
    Do temperature and time matter in cold agglutinin disease?
    Blood. 2020;136:380-381.
    >> Share

  254. BERENTSEN S, Barcellini W, D'Sa S, Randen U, et al
    Cold agglutinin disease revisited: a multinational, observational study of 232 patients.
    Blood. 2020;136:480-488.
    >> Share

  255. KATO GJ
    Sickle particulars of microparticles.
    Blood. 2020;136:154-155.
    >> Share

  256. GARNIER Y, Ferdinand S, Garnier M, Cita KC, et al
    Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties.
    Blood. 2020;136:247-256.
    >> Share

  257. EVANS EL, Povstyan OV, De Vecchis D, Macrae F, et al
    RBCs prevent rapid PIEZO1 inactivation and expose slow deactivation as a mechanism of dehydrated hereditary stomatocytosis.
    Blood. 2020;136:140-144.
    >> Share

    June 2020
  258. KHAN R, Menard M, Jen CC, Chen X, et al
    Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP.
    Blood. 2020;135:2420-2424.
    >> Share

  259. CHEN BY, Song J, Hu CL, Chen SB, et al
    SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
    Blood. 2020;135:2271-2285.
    >> Share

  260. HUANG P, Peslak SA, Lan X, Khandros E, et al
    The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression.
    Blood. 2020;135:2121-2132.
    >> Share

  261. WALTERS MC
    Sickle marrow: double, double toil and trouble.
    Blood. 2020;135:2017-2018.
    >> Share

  262. PARK SY, Matte A, Jung Y, Ryu J, et al
    Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion.
    Blood. 2020;135:2071-2084.
    >> Share

    May 2020
  263. KHANDROS E, Huang P, Peslak SA, Sharma M, et al
    Understanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A erythroblasts.
    Blood. 2020;135:1957-1968.
    >> Share

  264. GORDEUK VR
    Sickle cell vaso-occlusion: the clot thickens.
    Blood. 2020;135:1726-1727.
    >> Share

  265. SPARKENBAUGH EM, Chen C, Brzoska T, Nguyen J, et al
    Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease.
    Blood. 2020;135:1783-1787.
    >> Share

    April 2020
  266. SCHINDLER D, Kalb R
    Disease and mutation: correlations coming to fruition.
    Blood. 2020;135:1514-1515.
    >> Share

  267. APRILE A, Gulino A, Storto M, Villa I, et al
    Hematopoietic stem cell function in beta-thalassemia is impaired and is rescued by targeting the bone marrow niche.
    Blood. 2020 Apr 28. pii: 454666. doi: 10.1182/blood.2019002721.
    >> Share

  268. GHANNAM JY, Xu X, Maric I, Dillon L, et al
    Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation.
    Blood. 2020;135:1185-1188.
    >> Share

    March 2020
  269. SARAF SL
    Heme A1M'ed at the kidney in sickle cell disease.
    Blood. 2020;135:979-981.
    >> Share

  270. OFORI-ACQUAH SF, Hazra R, Orikogbo OO, Crosby D, et al
    Hemopexin deficiency promotes acute kidney injury in sickle cell disease.
    Blood. 2020;135:1044-1048.
    >> Share

  271. BRODSKY RA
    A complementary new drug for PNH.
    Blood. 2020;135:884-885.
    >> Share

  272. ROTH A, Nishimura JI, Nagy Z, Gaal-Weisinger J, et al
    The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria.
    Blood. 2020;135:912-920.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016